In COPD and ILD, vascular remodeling is known to be caused not only by alveolar hypoxia but also by factors contributing to endothelial dysfunction, such as increased endothelin-1, decreased prostacyclin and nitric oxide, increased oxidative stress, inflammation, and genetic predisposition [16,17]. This evidence concerns the gene EDN1 and chronic obstructive pulmonary disease.